Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 631 entries
Sorted by: Best Match Show Resources per page
Changes in primary metabolism under light and dark conditions in response to overproduction of a response regulator RpaA in the unicellular cyanobacterium Synechocystis sp. PCC 6803.

Frontiers in microbiology

Iijima H, Shirai T, Okamoto M, Kondo A, Hirai MY, Osanai T.
PMID: 26379657
Front Microbiol. 2015 Aug 26;6:888. doi: 10.3389/fmicb.2015.00888. eCollection 2015.

The study of the primary metabolism of cyanobacteria in response to light conditions is important for environmental biology because cyanobacteria are widely distributed among various ecological niches. Cyanobacteria uniquely possess circadian rhythms, with central oscillators consisting from three proteins,...

Cite
Iijima H, Shirai T, Okamoto M, et al. Changes in primary metabolism under light and dark conditions in response to overproduction of a response regulator RpaA in the unicellular cyanobacterium Synechocystis sp. PCC 6803. Front Microbiol. 2015;6:888doi: 10.3389/fmicb.2015.00888.
Iijima, H., Shirai, T., Okamoto, M., Kondo, A., Hirai, M. Y., & Osanai, T. (2015). Changes in primary metabolism under light and dark conditions in response to overproduction of a response regulator RpaA in the unicellular cyanobacterium Synechocystis sp. PCC 6803. Frontiers in microbiology, 6888. https://doi.org/10.3389/fmicb.2015.00888
Iijima, Hiroko, et al. "Changes in primary metabolism under light and dark conditions in response to overproduction of a response regulator RpaA in the unicellular cyanobacterium Synechocystis sp. PCC 6803." Frontiers in microbiology vol. 6 (2015): 888. doi: https://doi.org/10.3389/fmicb.2015.00888
Iijima H, Shirai T, Okamoto M, Kondo A, Hirai MY, Osanai T. Changes in primary metabolism under light and dark conditions in response to overproduction of a response regulator RpaA in the unicellular cyanobacterium Synechocystis sp. PCC 6803. Front Microbiol. 2015 Aug 26;6:888. doi: 10.3389/fmicb.2015.00888. eCollection 2015. PMID: 26379657; PMCID: PMC4549654.
Copy Download .nbib Format: NLM
Inverse association between central obesity and arterial stiffness in Korean subjects with metabolic syndrome: a cross-sectional cohort study.

Diabetology & metabolic syndrome

Won KB, Chang HJ, Niinuma H, Niwa K, Jeon K, Cho IJ, Shim CY, Hong GR, Chung N.
PMID: 25810782
Diabetol Metab Syndr. 2015 Jan 27;7:3. doi: 10.1186/1758-5996-7-3. eCollection 2015.

BACKGROUND: Metabolic syndrome (MetS) is associated with increased risks of diabetes and atherosclerotic cardiovascular disease. Whether central obesity (CeO) is a prerequisite for the diagnosis of MetS in the International Diabetes Federation (IDF) definition is a substantial issue because...

Cite
Won KB, Chang HJ, Niinuma H, et al. Inverse association between central obesity and arterial stiffness in Korean subjects with metabolic syndrome: a cross-sectional cohort study. Diabetol Metab Syndr. 2015;7:3doi: 10.1186/1758-5996-7-3.
Won, K. B., Chang, H. J., Niinuma, H., Niwa, K., Jeon, K., Cho, I. J., Shim, C. Y., Hong, G. R., & Chung, N. (2015). Inverse association between central obesity and arterial stiffness in Korean subjects with metabolic syndrome: a cross-sectional cohort study. Diabetology & metabolic syndrome, 73. https://doi.org/10.1186/1758-5996-7-3
Won, Ki-Bum, et al. "Inverse association between central obesity and arterial stiffness in Korean subjects with metabolic syndrome: a cross-sectional cohort study." Diabetology & metabolic syndrome vol. 7 (2015): 3. doi: https://doi.org/10.1186/1758-5996-7-3
Won KB, Chang HJ, Niinuma H, Niwa K, Jeon K, Cho IJ, Shim CY, Hong GR, Chung N. Inverse association between central obesity and arterial stiffness in Korean subjects with metabolic syndrome: a cross-sectional cohort study. Diabetol Metab Syndr. 2015 Jan 27;7:3. doi: 10.1186/1758-5996-7-3. eCollection 2015. PMID: 25810782; PMCID: PMC4373323.
Copy Download .nbib Format: NLM
Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir.

Journal of Cancer

Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, Nishimura T, Kita R, Kimura T, Iijima H, Nishiguchi S, Osaki Y.
PMID: 28243319
J Cancer. 2017 Jan 11;8(2):152-161. doi: 10.7150/jca.16523. eCollection 2017.

AIMS: We sought to compare the effects of FIB-4 index and aspartate aminotransferase to platelet ratio index (APRI) on hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients undergoing entecavir (ETV) therapy.PATIENT AND METHODS: A total of 338...

Cite
Nishikawa H, Nishijima N, Enomoto H, et al. Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir. J Cancer. 2017;8(2):152-161doi: 10.7150/jca.16523.
Nishikawa, H., Nishijima, N., Enomoto, H., Sakamoto, A., Nasu, A., Komekado, H., Nishimura, T., Kita, R., Kimura, T., Iijima, H., Nishiguchi, S., & Osaki, Y. (2017). Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir. Journal of Cancer, 8(2), 152-161. https://doi.org/10.7150/jca.16523
Nishikawa, Hiroki, et al. "Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir." Journal of Cancer vol. 8,2 (2017): 152-161. doi: https://doi.org/10.7150/jca.16523
Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, Nishimura T, Kita R, Kimura T, Iijima H, Nishiguchi S, Osaki Y. Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir. J Cancer. 2017 Jan 11;8(2):152-161. doi: 10.7150/jca.16523. eCollection 2017. PMID: 28243319; PMCID: PMC5327364.
Copy Download .nbib Format: NLM
Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation.

Hepatology research : the official journal of the Japan Society of Hepatology

Shinoda M, Ebinuma H, Itano O, Yamagishi Y, Obara H, Kitago M, Nakamoto N, Hibi T, Yagi H, Abe Y, Matsubara K, Chu PS, Wakayama Y, Taniki N, Yamaguchi A, Amemiya R, Miyake R, Mizota T, Kanai T, Kitagawa Y.
PMID: 26854748
Hepatol Res. 2016 Oct;46(11):1118-1128. doi: 10.1111/hepr.12666. Epub 2016 Apr 22.

AIM: Simeprevir (SMV) is a protease inhibitor which demonstrates good tolerability and high antiviral response in patients with hepatitis C. The clinical outcomes of triple therapy using simeprevir, pegylated interferon and ribavirin (SMV/PEG IFN/RBV) for recurrent hepatitis C after...

Cite
Shinoda M, Ebinuma H, Itano O, et al. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatol Res. 2016;46(11):1118-1128doi: 10.1111/hepr.12666.
Shinoda, M., Ebinuma, H., Itano, O., Yamagishi, Y., Obara, H., Kitago, M., Nakamoto, N., Hibi, T., Yagi, H., Abe, Y., Matsubara, K., Chu, P. S., Wakayama, Y., Taniki, N., Yamaguchi, A., Amemiya, R., Miyake, R., Mizota, T., Kanai, T., & Kitagawa, Y. (2016). Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatology research : the official journal of the Japan Society of Hepatology, 46(11), 1118-1128. https://doi.org/10.1111/hepr.12666
Shinoda, Masahiro, et al. "Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,11 (2016): 1118-1128. doi: https://doi.org/10.1111/hepr.12666
Shinoda M, Ebinuma H, Itano O, Yamagishi Y, Obara H, Kitago M, Nakamoto N, Hibi T, Yagi H, Abe Y, Matsubara K, Chu PS, Wakayama Y, Taniki N, Yamaguchi A, Amemiya R, Miyake R, Mizota T, Kanai T, Kitagawa Y. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatol Res. 2016 Oct;46(11):1118-1128. doi: 10.1111/hepr.12666. Epub 2016 Apr 22. PMID: 26854748.
Copy Download .nbib Format: NLM
Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome.

Journal of clinical biochemistry and nutrition

Takeda E, Yamanaka-Okumura H, Taketani Y, Inagaki N, Hosokawa M, Shide K, Maegawa H, Kondo K, Kawasaki E, Shinozaki S, Fujinaka Y, Matsubara T, Katayama T, Sasaki H, Kawashima A, Aonuma H.
PMID: 26388672
J Clin Biochem Nutr. 2015 Sep;57(2):140-4. doi: 10.3164/jcbn.14-132. Epub 2015 Aug 06.

The isomaltulose based liquid formula (MHN-01), suppresses postprandial plasma glucose and insulin levels in healthy persons and patients with impaired glucose tolerance (IGT) or type 2 diabetes. MHN-01 intake as a part of breakfast also suppresses glucose and insulin...

Cite
Takeda E, Yamanaka-Okumura H, Taketani Y, et al. Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome. J Clin Biochem Nutr. 2015;57(2):140-4doi: 10.3164/jcbn.14-132.
Takeda, E., Yamanaka-Okumura, H., Taketani, Y., Inagaki, N., Hosokawa, M., Shide, K., Maegawa, H., Kondo, K., Kawasaki, E., Shinozaki, S., Fujinaka, Y., Matsubara, T., Katayama, T., Sasaki, H., Kawashima, A., & Aonuma, H. (2015). Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome. Journal of clinical biochemistry and nutrition, 57(2), 140-4. https://doi.org/10.3164/jcbn.14-132
Takeda, Eiji, et al. "Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome." Journal of clinical biochemistry and nutrition vol. 57,2 (2015): 140-4. doi: https://doi.org/10.3164/jcbn.14-132
Takeda E, Yamanaka-Okumura H, Taketani Y, Inagaki N, Hosokawa M, Shide K, Maegawa H, Kondo K, Kawasaki E, Shinozaki S, Fujinaka Y, Matsubara T, Katayama T, Sasaki H, Kawashima A, Aonuma H. Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome. J Clin Biochem Nutr. 2015 Sep;57(2):140-4. doi: 10.3164/jcbn.14-132. Epub 2015 Aug 06. PMID: 26388672; PMCID: PMC4566023.
Copy Download .nbib Format: NLM
A case of severe cholestatic jaundice with hyperthyroidism successfully treated with methimazole.

Clinical journal of gastroenterology

Ichikawa H, Ebinuma H, Tada S, Ojiro K, Yamagishi Y, Tsukada N, Hongou E, Funae O, Irie R, Saito H, Hibi T.
PMID: 26192433
Clin J Gastroenterol. 2009 Aug;2(4):315-319. doi: 10.1007/s12328-009-0094-8. Epub 2009 Jun 17.

Liver dysfunction is a common complication observed in patients with hyperthyroidism, however the dysfunction is always mild and obvious jaundice is rarely observed. We present the case of a 43-year-old man who suffered from hyperthyroidism complicated by severe jaundice....

Cite
Ichikawa H, Ebinuma H, Tada S, et al. A case of severe cholestatic jaundice with hyperthyroidism successfully treated with methimazole. Clin J Gastroenterol. 2009;2(4):315-319doi: 10.1007/s12328-009-0094-8.
Ichikawa, H., Ebinuma, H., Tada, S., Ojiro, K., Yamagishi, Y., Tsukada, N., Hongou, E., Funae, O., Irie, R., Saito, H., & Hibi, T. (2009). A case of severe cholestatic jaundice with hyperthyroidism successfully treated with methimazole. Clinical journal of gastroenterology, 2(4), 315-319. https://doi.org/10.1007/s12328-009-0094-8
Ichikawa, Hitoshi, et al. "A case of severe cholestatic jaundice with hyperthyroidism successfully treated with methimazole." Clinical journal of gastroenterology vol. 2,4 (2009): 315-319. doi: https://doi.org/10.1007/s12328-009-0094-8
Ichikawa H, Ebinuma H, Tada S, Ojiro K, Yamagishi Y, Tsukada N, Hongou E, Funae O, Irie R, Saito H, Hibi T. A case of severe cholestatic jaundice with hyperthyroidism successfully treated with methimazole. Clin J Gastroenterol. 2009 Aug;2(4):315-319. doi: 10.1007/s12328-009-0094-8. Epub 2009 Jun 17. PMID: 26192433.
Copy Download .nbib Format: NLM
Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients.

Hepatology research : the official journal of the Japan Society of Hepatology

Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Ishii A, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.
PMID: 26787135
Hepatol Res. 2016 Oct;46(11):1065-1073. doi: 10.1111/hepr.12655. Epub 2016 May 26.

AIM: To examine the impact of pretreatment Wisteria floribunda agglutinin positive Mac-2-binding protein (WFAMETHODS: A total of 57 patients were analyzed. All subjects were initially treated with NUC. We examined the impact of pretreatment WFARESULTS: There were 36 men...

Cite
Nishikawa H, Enomoto H, Iwata Y, et al. Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients. Hepatol Res. 2016;46(11):1065-1073doi: 10.1111/hepr.12655.
Nishikawa, H., Enomoto, H., Iwata, Y., Kishino, K., Shimono, Y., Hasegawa, K., Nakano, C., Takata, R., Nishimura, T., Yoh, K., Ishii, A., Aizawa, N., Sakai, Y., Ikeda, N., Takashima, T., Iijima, H., & Nishiguchi, S. (2016). Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients. Hepatology research : the official journal of the Japan Society of Hepatology, 46(11), 1065-1073. https://doi.org/10.1111/hepr.12655
Nishikawa, Hiroki, et al. "Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,11 (2016): 1065-1073. doi: https://doi.org/10.1111/hepr.12655
Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Ishii A, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients. Hepatol Res. 2016 Oct;46(11):1065-1073. doi: 10.1111/hepr.12655. Epub 2016 May 26. PMID: 26787135.
Copy Download .nbib Format: NLM
Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count.

Hepatology research : the official journal of the Japan Society of Hepatology

Ikeda N, Imanishi H, Aizawa N, Tanaka H, Iwata Y, Enomoto H, Saito M, Iijima H, Iimuro Y, Fujimoto J, Yamamoto S, Hirota S, Kudo M, Arii S, Nishiguchi S.
PMID: 23763386
Hepatol Res. 2014 Aug;44(8):829-36. doi: 10.1111/hepr.12184. Epub 2013 Aug 07.

AIM: In chronic liver disease associated with hepatitis C virus (HCV), a low platelet count is a major obstacle in carrying out interferon (IFN) treatment. We used a questionnaire to clarify the extent to which splenectomy/partial splenic embolization (PSE)...

Cite
Ikeda N, Imanishi H, Aizawa N, et al. Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count. Hepatol Res. 2013;44(8):829-36doi: 10.1111/hepr.12184.
Ikeda, N., Imanishi, H., Aizawa, N., Tanaka, H., Iwata, Y., Enomoto, H., Saito, M., Iijima, H., Iimuro, Y., Fujimoto, J., Yamamoto, S., Hirota, S., Kudo, M., Arii, S., & Nishiguchi, S. (2014). Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count. Hepatology research : the official journal of the Japan Society of Hepatology, 44(8), 829-36. https://doi.org/10.1111/hepr.12184
Ikeda, Naoto, et al. "Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count." Hepatology research : the official journal of the Japan Society of Hepatology vol. 44,8 (2014): 829-36. doi: https://doi.org/10.1111/hepr.12184
Ikeda N, Imanishi H, Aizawa N, Tanaka H, Iwata Y, Enomoto H, Saito M, Iijima H, Iimuro Y, Fujimoto J, Yamamoto S, Hirota S, Kudo M, Arii S, Nishiguchi S. Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count. Hepatol Res. 2014 Aug;44(8):829-36. doi: 10.1111/hepr.12184. Epub 2013 Aug 07. PMID: 23763386.
Copy Download .nbib Format: NLM
Spin-filter tunnel junction with matched fermi surfaces.

Physical review letters

Harada T, Ohkubo I, Lippmaa M, Sakurai Y, Matsumoto Y, Muto S, Koinuma H, Oshima M.
PMID: 23006390
Phys Rev Lett. 2012 Aug 17;109(7):076602. doi: 10.1103/PhysRevLett.109.076602. Epub 2012 Aug 16.

Efficient injection of spin-polarized current into a semiconductor is a basic prerequisite for building semiconductor-based spintronic devices. Here, we use inelastic electron tunneling spectroscopy to show that the efficiency of spin-filter-type spin injectors is limited by spin scattering of...

Cite
Harada T, Ohkubo I, Lippmaa M, et al. Spin-filter tunnel junction with matched fermi surfaces. Phys Rev Lett. 2012;109(7):076602doi: 10.1103/PhysRevLett.109.076602.
Harada, T., Ohkubo, I., Lippmaa, M., Sakurai, Y., Matsumoto, Y., Muto, S., Koinuma, H., & Oshima, M. (2012). Spin-filter tunnel junction with matched fermi surfaces. Physical review letters, 109(7), 076602. https://doi.org/10.1103/PhysRevLett.109.076602
Harada, T, et al. "Spin-filter tunnel junction with matched fermi surfaces." Physical review letters vol. 109,7 (2012): 076602. doi: https://doi.org/10.1103/PhysRevLett.109.076602
Harada T, Ohkubo I, Lippmaa M, Sakurai Y, Matsumoto Y, Muto S, Koinuma H, Oshima M. Spin-filter tunnel junction with matched fermi surfaces. Phys Rev Lett. 2012 Aug 17;109(7):076602. doi: 10.1103/PhysRevLett.109.076602. Epub 2012 Aug 16. PMID: 23006390.
Copy Download .nbib Format: NLM
[NMR: preparation of a signal intensity map for the NMR-CT diagnosis].

Kaku igaku. The Japanese journal of nuclear medicine

Torii S, Ikehira H, Fukuda N, Iinuma T, Tateno Y, Matsumoto T, Maki T, Takeda J.
PMID: 6530827
Kaku Igaku. 1984 Nov;21(11):1481-5.

No abstract available.

Cite
Torii S, Ikehira H, Fukuda N, et al. [NMR: preparation of a signal intensity map for the NMR-CT diagnosis]. Kaku Igaku. 1984;21(11):1481-5
Torii, S., Ikehira, H., Fukuda, N., Iinuma, T., Tateno, Y., Matsumoto, T., Maki, T., & Takeda, J. (1984). [NMR: preparation of a signal intensity map for the NMR-CT diagnosis]. Kaku igaku. The Japanese journal of nuclear medicine, 21(11), 1481-5.
Torii, S, et al. "[NMR: preparation of a signal intensity map for the NMR-CT diagnosis]." Kaku igaku. The Japanese journal of nuclear medicine vol. 21,11 (1984): 1481-5.
Torii S, Ikehira H, Fukuda N, Iinuma T, Tateno Y, Matsumoto T, Maki T, Takeda J. [NMR: preparation of a signal intensity map for the NMR-CT diagnosis]. Kaku Igaku. 1984 Nov;21(11):1481-5. Japanese. PMID: 6530827.
Copy Download .nbib Format: NLM
Selection of marker-free transgenic plants using the isopentenyl transferase gene.

Proceedings of the National Academy of Sciences of the United States of America

Ebinuma H, Sugita K, Matsunaga E, Yamakado M.
PMID: 11038607
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2117-21. doi: 10.1073/pnas.94.6.2117.

We have developed a new plant vector system for repeated transformation (called MAT for multi-auto-transformation) in which a chimeric ipt gene, inserted into the transposable element Ac, is used as a selectable marker for transformation. Selectable marker genes conferring...

Cite
Ebinuma H, Sugita K, Matsunaga E, et al. Selection of marker-free transgenic plants using the isopentenyl transferase gene. Proc Natl Acad Sci U S A. 1997;94(6):2117-21doi: 10.1073/pnas.94.6.2117.
Ebinuma, H., Sugita, K., Matsunaga, E., & Yamakado, M. (1997). Selection of marker-free transgenic plants using the isopentenyl transferase gene. Proceedings of the National Academy of Sciences of the United States of America, 94(6), 2117-21. https://doi.org/10.1073/pnas.94.6.2117
Ebinuma, H, et al. "Selection of marker-free transgenic plants using the isopentenyl transferase gene." Proceedings of the National Academy of Sciences of the United States of America vol. 94,6 (1997): 2117-21. doi: https://doi.org/10.1073/pnas.94.6.2117
Ebinuma H, Sugita K, Matsunaga E, Yamakado M. Selection of marker-free transgenic plants using the isopentenyl transferase gene. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2117-21. doi: 10.1073/pnas.94.6.2117. PMID: 11038607; PMCID: PMC20050.
Copy Download .nbib Format: NLM
Chronic high-dose nitrazepam dependence 123I-IMP SPECT and EEG studies.

Addiction biology

Kitabayashi Y, Ueda H, Narumoto J, Iizumi H, Tsuchida H, Murata N, Nakajima S, Fukui K.
PMID: 11900604
Addict Biol. 2001 Jul;6(3):257-261. doi: 10.1080/13556210120056507.

A patient who took 50-100 mg nitrazepam per day for 25 years is presented. (123)I-IMP SPECT (autoradiography method) and EEG were performed sequentially on the subject during and after the withdrawal syndrome. Severe hypoperfusion of the whole brain on...

Cite
Kitabayashi Y, Ueda H, Narumoto J, et al. Chronic high-dose nitrazepam dependence 123I-IMP SPECT and EEG studies. Addict Biol. 2001;6(3):257-261doi: 10.1080/13556210120056507.
Kitabayashi, Y., Ueda, H., Narumoto, J., Iizumi, H., Tsuchida, H., Murata, N., Nakajima, S., & Fukui, K. (2001). Chronic high-dose nitrazepam dependence 123I-IMP SPECT and EEG studies. Addiction biology, 6(3), 257-261. https://doi.org/10.1080/13556210120056507
Kitabayashi, Yurinosuke, et al. "Chronic high-dose nitrazepam dependence 123I-IMP SPECT and EEG studies." Addiction biology vol. 6,3 (2001): 257-261. doi: https://doi.org/10.1080/13556210120056507
Kitabayashi Y, Ueda H, Narumoto J, Iizumi H, Tsuchida H, Murata N, Nakajima S, Fukui K. Chronic high-dose nitrazepam dependence 123I-IMP SPECT and EEG studies. Addict Biol. 2001 Jul;6(3):257-261. doi: 10.1080/13556210120056507. PMID: 11900604.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 631 entries